ProGnosis Biotech
Pre-clinicalProGnosis Biotech specializes in developing modern in-vitro testing technologies for use in the food, beverage, agriculture and clinical diagnostics markets.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.1M
About
ProGnosis Biotech specializes in developing modern in-vitro testing technologies for use in the food, beverage, agriculture and clinical diagnostics markets.
Diagnostics
Funding History
1Total raised:$2.1M
Seed$2.1MNov 15, 2022